Jeffrey Perl


Associate Scientist, Li Ka Shing Knowledge Institute


Dr. Jeffrey Perl received his MD from the University of Toronto in 2003, where he also completed his post-graduate training in both Internal Medicine and Nephrology in 2008. In 2010, he completed his Masters of Science in Clinical Epidemiology from The Harvard School of Public Health.

Dr. Perl is currently a Staff Nephrologist at St Michael’s Hospital in Toronto and an Assistant Professor in the Department of Medicine at the University of Toronto. He currently chairs the International Society of Nephrology’s Young Nephrologists Committee. His primary research interests and clinical practice focuses on improving the survival and quality of life for patients on peritoneal dialysis. Dr. Perl is a primary investigator in The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).

Recent Publications

  1. Trinh, E, Perl, J. The Patient Receiving Automated Peritoneal Dialysis with Volume Overload. Clin J Am Soc Nephrol. 2018;13 (11):1732-1734. doi: 10.2215/CJN.02570218. PubMed PMID:30201730 .
  2. Boudville, N, Johnson, DW, Zhao, J, Bieber, BA, Pisoni, RL, Piraino, B et al.. Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns Study. Nephrol. Dial. Transplant. 2018; :. doi: 10.1093/ndt/gfy204. PubMed PMID:30053214 .
  3. Molnar, AO, Moist, L, Klarenbach, S, Lafrance, JP, Kim, SJ, Tennankore, K et al.. Hospitalizations in Dialysis Patients in Canada: A National Cohort Study. Can J Kidney Health Dis. 2018;5 :2054358118780372. doi: 10.1177/2054358118780372. PubMed PMID:29900002 PubMed Central PMC5985541.
  4. Perl, J, McArthur, E, Tan, VS, Nash, DM, Garg, AX, Harel, Z et al.. ESRD among Immigrants to Ontario, Canada: A Population-Based Study. J. Am. Soc. Nephrol. 2018;29 (7):1948-1959. doi: 10.1681/ASN.2017101055. PubMed PMID:29720548 PubMed Central PMC6050933.
  5. Trottier, C, Perl, J, Freeman, M, Thadhani, R, Berg, A, Kalim, S et al.. Protein Carbamylation in Peritoneal Dialysis and the Effect of Low Glucose Plus Amino Acid Solutions. Perit Dial Int. ;38 (2):149-152. doi: 10.3747/pdi.2017.00176. PubMed PMID:29563277 .
  6. Trinh, E, Chan, CT, Perl, J. Dialysis modality and survival: Done to death. Semin Dial. 2018;31 (4):315-324. doi: 10.1111/sdi.12692. PubMed PMID:29539161 .
  7. Kalim, S, Wald, R, Yan, AT, Goldstein, MB, Kiaii, M, Xu, D et al.. Extended Duration Nocturnal Hemodialysis and Changes in Plasma Metabolite Profiles. Clin J Am Soc Nephrol. 2018;13 (3):436-444. doi: 10.2215/CJN.08790817. PubMed PMID:29444900 PubMed Central PMC5967674.
  8. Shahid, K, Streutker, CJ, Kim, RH, Colak, E, Shin, HS, Pace, KT et al.. A Case of a "Voiding" Hypertension. Kidney Int Rep. 2017;2 (5):973-977. doi: 10.1016/j.ekir.2017.02.018. PubMed PMID:29270506 PubMed Central PMC5733881.
  9. Tennankore, KK, Na, Y, Wald, R, Chan, CT, Perl, J. Short daily-, nocturnal- and conventional-home hemodialysis have similar patient and treatment survival. Kidney Int. 2018;93 (1):188-194. doi: 10.1016/j.kint.2017.06.014. PubMed PMID:28844317 .
  10. Trinh, E, Na, Y, Sood, MM, Chan, CT, Perl, J. Racial Differences in Home Dialysis Utilization and Outcomes in Canada. Clin J Am Soc Nephrol. 2017;12 (11):1841-1851. doi: 10.2215/CJN.03820417. PubMed PMID:28835369 PubMed Central PMC5672971.
Search PubMed

Affiliations & Other Activities

  • Nephrologist, Division of Nephrology, St. Michael’s Hospital
  • Assistant Professor of Medicine, University of Toronto
  • Chair, International Society of Nephrology’s Young Nephrologists Committee